CathOlic Medical Center percutAneous Coronary inTervention Registry (COACT)
COACT
1 other identifier
observational
11,719
1 country
8
Brief Summary
COACT registry is a multicenter registry of consecutive patients undergoing coronary stent implantation at 8 centers in the Catholic University of Korea to evaluate the real world management of patients with coronary artery disease and to assess their in-hospital, medium and long-term outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2005
Longer than P75 for all trials
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2005
CompletedFirst Submitted
Initial submission to the registry
November 12, 2010
CompletedFirst Posted
Study publicly available on registry
November 15, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2019
CompletedSeptember 7, 2022
September 1, 2022
14.9 years
November 12, 2010
September 2, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
All causes mortality
6month, each year
Cardiac death
6 month, each year
Myocardial infarction
6 month, each year
target lesion revascularization
6 month, each year
target vessel revascularization
6 month, each year
Secondary Outcomes (4)
non target vessel revascularization
6 month, each year
Stent thrombosis
6 month, each year
Serum databank for evaluation of biomarkers outcomes
6 month, each year
Pharmacogenetic and cardiovascular genetic studies associated to clinical outcomes
6 month, each year
Eligibility Criteria
all comers who admitted cardiovascular center for coronary stent implantation
You may qualify if:
- all consecutive patients who underwent percutaneous coronary intervention
- written informed consent for the DNA and serum databank
You may not qualify if:
- patients who did not agreed to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The Catholic University of Korealead
- Seoul St. Mary's Hospitalcollaborator
- Yeouido St. Mary's Hospitalcollaborator
- Bucheon St. Mary's Hospitalcollaborator
- St.Paul's Hospital, Koreacollaborator
- Incheon St.Mary's Hospitalcollaborator
- Saint Vincent's Hospital, Koreacollaborator
- Daejeon St. Mary's hospitalcollaborator
Study Sites (8)
Bucheon St.Mary Hospital
Bucheon-si, Gyeonggido, South Korea
St.Vincent's Hospital
Suwon, Gyeonggido, South Korea
Uijeongbu St.Mary's Hospital
Uijeongbu-si, Gyeonggido, South Korea
Daejeon St.Mary's Hospital
Daejeon, South Korea
Incheon St.Mary's Hospital
Incheon, South Korea
Seoul St.Mary's Hospital
Seoul, 137-701, South Korea
St.Paul's Hospital
Seoul, South Korea
Yeouido St.Mary Hospital
Seoul, South Korea
Related Publications (1)
Kim HS, Chang K, Koh YS, Park MW, Choi YS, Park CS, Oh M, Kim EY, Shon JH, Shin JG, Seung KB. CYP2C19 poor metabolizer is associated with clinical outcome of clopidogrel therapy in acute myocardial infarction but not stable angina. Circ Cardiovasc Genet. 2013 Oct;6(5):514-21. doi: 10.1161/CIRCGENETICS.113.000109. Epub 2013 Sep 9.
PMID: 24019397DERIVED
Biospecimen
Whole blood, serum and DNA
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Ki-Bae Seung, M.D.,PhD
Seoul St. Mary's Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
November 12, 2010
First Posted
November 15, 2010
Study Start
January 1, 2005
Primary Completion
December 1, 2019
Study Completion
December 1, 2019
Last Updated
September 7, 2022
Record last verified: 2022-09